Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate

By Rosen Steven D   Lemjabbar-Alaoui Hassan  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 9, 2010-09 ,pp. : 935-949

Informa Healthcare

Access to resources Recommend Favorite

Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 4, 2004-06 ,pp. : 327-336

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting angiopoietin-2 signaling in cancer therapy

By Eroglu Zeynep   Stein Cy A   Pal Sumanta K  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. : 813-825

Informa Healthcare

Access to resources Recommend Favorite

HER-2 Signaling and Inhibition in Breast Cancer

By  

Current Cancer Drug Targets, Vol. 9, Iss. 3, 2009-05 ,pp. : 419-438

Bentham Science Publishers

Access to resources Recommend Favorite

Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways

By  

Current Cancer Drug Targets, Vol. 15, Iss. 1, 2015-01 ,pp. : 14-26

Bentham Science Publishers

Access to resources Recommend Favorite